Shanghai Henlius Biotech, Inc. (2696.HK) and Organon today announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback